Anna Helhoski

Well, because what constitutes an official made-in-America product is up to the Federal Trade Commission, and it has been for decades. In 1997, the FTC provided some guidance for companies to use the made-in-USA label. The standard is that all or virtually all of a product advertised as made-in-the-USA must be made in the U.S.,

Well, because what constitutes an official made-in-America product is up to the Federal Trade Commission, and it has been for decades. In 1997, the FTC provided some guidance for companies to use the made-in-USA label. The standard is that all or virtually all of a product advertised as made-in-the-USA must be made in the U.S.,

A company doesn't have to disclose if their product is made in the U.S., but if it wants to label it made in the U.S., then it must follow the all or virtually all standard laid out by the FTC.

A company doesn't have to disclose if their product is made in the U.S., but if it wants to label it made in the U.S., then it must follow the all or virtually all standard laid out by the FTC.

A company doesn't have to disclose if their product is made in the U.S., but if it wants to label it made in the U.S., then it must follow the all or virtually all standard laid out by the FTC.

So virtually all means that a product manufactured in the U.S. could still use foreign imports as part of the production process. Many American companies with manufacturing in the U.S. will still rely on global supply chains to complete products. Crayola is a really good example of this. Its corporate headquarters is in Pennsylvania, and it also has manufacturing facilities there and in Mexico.

So virtually all means that a product manufactured in the U.S. could still use foreign imports as part of the production process. Many American companies with manufacturing in the U.S. will still rely on global supply chains to complete products. Crayola is a really good example of this. Its corporate headquarters is in Pennsylvania, and it also has manufacturing facilities there and in Mexico.

So virtually all means that a product manufactured in the U.S. could still use foreign imports as part of the production process. Many American companies with manufacturing in the U.S. will still rely on global supply chains to complete products. Crayola is a really good example of this. Its corporate headquarters is in Pennsylvania, and it also has manufacturing facilities there and in Mexico.

Like many U.S.-based companies, Crayola is not operating fully independent of global supply chains. And for that reason, tariffs present a challenge for so many U.S. companies. And what are some of those challenges? Well, it means U.S.-based companies will face import costs for components that they require from foreign countries. And they're likely to pass those extra costs along to U.S.

Like many U.S.-based companies, Crayola is not operating fully independent of global supply chains. And for that reason, tariffs present a challenge for so many U.S. companies. And what are some of those challenges? Well, it means U.S.-based companies will face import costs for components that they require from foreign countries. And they're likely to pass those extra costs along to U.S.

Like many U.S.-based companies, Crayola is not operating fully independent of global supply chains. And for that reason, tariffs present a challenge for so many U.S. companies. And what are some of those challenges? Well, it means U.S.-based companies will face import costs for components that they require from foreign countries. And they're likely to pass those extra costs along to U.S.

consumers, at least in part, if not fully. But many of these products likely can't be made entirely in the U.S. right now, so there's not much choice they have there. A car is a really great example. Huge auto companies are based in the U.S., Ford, General Motors, and Stellantis. And they may assemble domestically, but assembly is the final step in the manufacturing process.

consumers, at least in part, if not fully. But many of these products likely can't be made entirely in the U.S. right now, so there's not much choice they have there. A car is a really great example. Huge auto companies are based in the U.S., Ford, General Motors, and Stellantis. And they may assemble domestically, but assembly is the final step in the manufacturing process.

consumers, at least in part, if not fully. But many of these products likely can't be made entirely in the U.S. right now, so there's not much choice they have there. A car is a really great example. Huge auto companies are based in the U.S., Ford, General Motors, and Stellantis. And they may assemble domestically, but assembly is the final step in the manufacturing process.

It takes something like 30,000 parts to make a car. So somewhere in that sourcing, producing and shipping processes are going to be non-American goods. And every time those parts cross borders, they'll face tariffs. So not only are U.S. cars not really 100% made in the U.S., they're likely to get more expensive the longer tariffs are in place. Pharmaceuticals are another example. A U.S.

It takes something like 30,000 parts to make a car. So somewhere in that sourcing, producing and shipping processes are going to be non-American goods. And every time those parts cross borders, they'll face tariffs. So not only are U.S. cars not really 100% made in the U.S., they're likely to get more expensive the longer tariffs are in place. Pharmaceuticals are another example. A U.S.

It takes something like 30,000 parts to make a car. So somewhere in that sourcing, producing and shipping processes are going to be non-American goods. And every time those parts cross borders, they'll face tariffs. So not only are U.S. cars not really 100% made in the U.S., they're likely to get more expensive the longer tariffs are in place. Pharmaceuticals are another example. A U.S.

company may produce a finished product, say a bottle of pills, in the U.S., but its active pharmaceutical ingredients, or APIs, are crucial to finishing it. Most of those APIs are going to come from China, and those APIs are currently subject to tariffs. So it's likely that the prices of drugs that include foreign-sourced components will increase.

company may produce a finished product, say a bottle of pills, in the U.S., but its active pharmaceutical ingredients, or APIs, are crucial to finishing it. Most of those APIs are going to come from China, and those APIs are currently subject to tariffs. So it's likely that the prices of drugs that include foreign-sourced components will increase.

company may produce a finished product, say a bottle of pills, in the U.S., but its active pharmaceutical ingredients, or APIs, are crucial to finishing it. Most of those APIs are going to come from China, and those APIs are currently subject to tariffs. So it's likely that the prices of drugs that include foreign-sourced components will increase.